Hypertension Approaches in the Elderly: a Lifestyle Study
NCT03264443, Not applicable, Unknown, Hospital de Clinicas de Porto Alegre
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Hypertension Approaches in the Elderly: a Lifestyle Study | ClinicalTrials.gov |
| NCT number | NCT03264443 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 184 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Hospital de Clinicas de Porto Alegre | ClinicalTrials.gov |
| Conditions | Hypertension | ClinicalTrials.gov |
| Interventions | Health education, Combined training | ClinicalTrials.gov |
| First posted | 2017-08-29 | ClinicalTrials.gov |
| Last updated | 2020-02-12 | ClinicalTrials.gov |
Registered outcomes 9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Ambulatory Blood Pressure | Change from baseline 24-hour systolic blood pressure at 12 weeks | 24h ambulatory blood pressure measured through automatic oscillometric device | ClinicalTrials.gov |
| Secondary | Walking distance | Change from baseline walking distance at 12 weeks | Longest distance walked as assessed by the six-minute walk test | ClinicalTrials.gov |
| Secondary | Lower limbs functional capacity | Change from baseline SPPB score at 12 weeks | By using the Short Physical Performance Battery (SPPB), lower-limb mobility will be assess in the following sequence: static standing balance, walking speed and indirect muscle strength | ClinicalTrials.gov |
| Secondary | Cardiorespiratory fitness | Change from baseline VO2peak at 12 weeks | Oxygen consumption at peak (VO2peak) as assessed by maximal cardiopulmonary exercise testing | ClinicalTrials.gov |
| Secondary | Geriatric Depression Symptoms | Change from baseline GDS-15 score at 12 weeks | 15-item depression symptoms scale (GDS-15) | ClinicalTrials.gov |
| Secondary | Quality of life (QoL) | Change from baseline QoL score at 12 weeks | World Health Organization Quality of Life questionnaire | ClinicalTrials.gov |
| Secondary | Autonomic function | Change from baseline beat-to-beat blood pressure variability at 12 weeks | Basal and during Stroop Color-Word Conflict Test beat-to-beat blood pressure variability | ClinicalTrials.gov |
| Secondary | Endothelial function, early adaptation | Change from baseline FMD at 6 weeks | Flow-mediated dilatation (FMD) assessed through high resolution ultrasonography | ClinicalTrials.gov |
| Secondary | Endothelial function | Change from baseline FMD at 12 weeks | Flow-mediated dilatation (FMD) assessed through high resolution ultrasonography | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 2
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)